SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
12.08
-0.82 (-6.36%)
At close: Jul 22, 2026, 4:00 PM EDT
11.95
-0.13 (-1.07%)
After-hours: Jul 22, 2026, 7:59 PM EDT
SLS Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
2.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.00M | -6.60M | -86.84% |
| Dec 31, 2021 | 7.60M | 5.70M | 300.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tarsus Pharmaceuticals | 535.08M |
| Iovance Biotherapeutics | 285.61M |
| Nurix Therapeutics | 36.77M |
| Immunome | 4.02M |
| AtaiBeckley | 3.49M |
SLS News
- 5 days ago - Sellas Life Sciences rises 11.0% - TheFly
- 5 days ago - Sellas Life Sciences rises 10.2% - TheFly
- 16 days ago - Sellas Life Sciences price target raised to $25 from $10 at Alliance Global - TheFly
- 21 days ago - Sellas Life Sciences falls -11.0% - TheFly
- 22 days ago - Sellas Life Sciences falls -8.9% - TheFly
- 23 days ago - Sellas Life Sciences rises 16.8% - TheFly
- 26 days ago - What's driving SLS stock higher today and what comes next? - Invezz
- 5 weeks ago - SELLAS Life Sciences Group Transcript: AGM 2026 - Transcripts